Methotrexate Tablets
( DrugBank: Methotrexate / KEGG DRUG: Methotrexate )
2 diseases
40. 高安動脈炎
臨床試験数 : 24 / 薬物数 : 40 - (DrugBank : 18) / 標的遺伝子数 : 23 - 標的パスウェイ数 : 110
Showing 1 to 1 of 1 trials
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT04299971 (ClinicalTrials.gov) | March 1, 202020200301 | 5/3/202020200305 | Efficiency of Methotrexate and Tofacitinib in Mild and Moderate Patients | Randomized Open-label Study in Mild and Moderate Patients With Takayasu Arteritis Between Methotrexate and Tofacitinib Based on the ECTA Cohort. Randomized Open-label Study in Mild and Moderate Patients With Takayasu Arteritis Between Methotrexa ... | Takayasu Arteritis;Methotrexate;Inhibition;Treatment | Drug: Methotrexate Tablets;Drug: Tofacitinib tablet | Shanghai Zhongshan Hospital | NULL | Recruiting | 14 Years | 100 Years | All | 130 | Phase 4 | China |
46. 悪性関節リウマチ
臨床試験数 : 4,356 / 薬物数 : 2,567 - (DrugBank : 415) / 標的遺伝子数 : 192 - 標的パスウェイ数 : 228
Showing 1 to 10 of 26 trials
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | ITMCTR2200006086 | 2022-07-0120220701 | 2022-06-1020220610 | Multicenter randomized double-blind clinical trial of Qufeng Zhitong Capsule combined with Methotrexate tablets in the treatment of rheumatoid arthritis Multicenter randomized double-blind clinical trial of Qufeng Zhitong Capsule combined with Methotrex ... | Multicenter randomized double-blind clinical trial of Qufeng Zhitong Capsule combined with Methotrexate tablets in the treatment of rheumatoid arthritis Multicenter randomized double-blind clinical trial of Qufeng Zhitong Capsule combined with Methotrex ... | rheumatoid arthritis | matched group:Methotrexate tablet + qufeng analgesic capsule simulato;experimental group:Methotrexate tablet + qufeng analgesic capsule; matched group:Methotrexate tablet + qufeng analgesic capsule simulato;experimental group:Methotrexat ... | Guang 'anmen Hospital, China Academy of Traditional Chinese Medicine | NULL | Pending | 18 | 75 | Both | matched group:100;experimental group:100; | Phase 4 | China |
2 | NCT05380934 (ClinicalTrials.gov) | May 202220220500 | 16/5/202220220516 | A Clinical Trial of Safety and Tolerance of TQH3821 Tablets in Adult Healthy Subjects | A Randomized, Double-blind, Placebo-controlled Phase I Clinical Trial of TQH3821 in Adult Healthy Subjects A Randomized, Double-blind, Placebo-controlled Phase I Clinical Trial of TQH3821 in Adult Healthy Su ... | Rheumatoid Arthritis | Drug: TQH3821 tablets;Drug: TQH3821 tablets (Placebo);Drug: Methotrexate tablets | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | NULL | Recruiting | 18 Years | 55 Years | All | 62 | Phase 1 | China |
3 | ChiCTR2100054305 | 2021-12-0120211201 | 2021-12-1320211213 | Observation on the clinical efficacy of Jiawei Qianyang Fengsui Dan in the treatment of RA with mixed syndrome of cold and heat Observation on the clinical efficacy of Jiawei Qianyang Fengsui Dan in the treatment of RA with mixe ... | Observation on the clinical efficacy of Jiawei Qianyang Fengsui Dan in the treatment of RA with mixed syndrome of cold and heat Observation on the clinical efficacy of Jiawei Qianyang Fengsui Dan in the treatment of RA with mixe ... | Rheumatoid Arthritis | Treatment group:Modified Qianyang Fengsui Dan + Methotrexate Tablets + Folic Acid Tablets;Control group:Methotrexate + Folic Acid; Treatment group:Modified Qianyang Fengsui Dan + Methotrexate Tablets+ Folic Acid Tablets;Control gro ... | Yunnan Provincial Hospital of Traditional Chinese Medicine | NULL | Recruiting | 18 | 70 | Both | Treatment group:36;Control group:36; | China | |
4 | ChiCTR2100048769 | 2021-09-2920210929 | 2021-07-1620210716 | Prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial of Qufengzhitong capsule in the treatment of rheumatoid arthritis Prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial of Qufengzhito ... | Prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial of Qufengzhitong capsule in the treatment of rheumatoid arthritis Prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial of Qufengzhito ... | rheumatoid arthritis | Test group:Methotrexate tablets+Qufengzhitong capsule;control group:Methotrexate tablets+Qufeng Zhitong Capsule Placebo; Test group:Methotrexate tablets+Qufengzhitong capsule;control group:Methotrexate tablets+Qufeng Zhit ... | Guang'anmen Hospital, China Academy of Chinese Medical Sciences | NULL | Pending | 18 | 75 | Both | Test group:102;control group:102; | Phase 4 | china |
5 | ITMCTR2100005057 | 2021-09-2920210929 | 2021-07-1620210716 | Prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial of Qufengzhitong capsule in the treatment of rheumatoid arthritis Prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial of Qufengzhito ... | Prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial of Qufengzhitong capsule in the treatment of rheumatoid arthritis Prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial of Qufengzhito ... | rheumatoid arthritis | control group:Methotrexate tablets+Qufeng Zhitong Capsule Placebo;Test group:Methotrexate tablets+Qufengzhitong capsule; control group:Methotrexate tablets+Qufeng Zhitong Capsule Placebo;Test group:Methotrexate tablets+Qu ... | Guang'anmen Hospital, China Academy of Chinese Medical Sciences | NULL | Pending | 18 | 75 | Both | control group:102;Test group:102; | Phase 4 | china |
6 | ChiCTR2100042659 | 2021-01-2520210125 | 2021-01-2520210125 | Observation on the clinical effect of treating rheumatoid arthritis based on the theory of kidney deficiency and cold coagulation Observation on the clinical effect of treating rheumatoid arthritis based on the theory of kidney de ... | Observation on the clinical effect of treating rheumatoid arthritis based on the theory of kidney deficiency and cold coagulation Observation on the clinical effect of treating rheumatoid arthritis based on the theory of kidney de ... | Rheumatoid Arthritis | experimental group:Fuzi Guizhi Decoction granules+Methotrexate tablets + Folic acid tablets;control group:Methotrexate tablets + Folic acid tablets; experimental group:Fuzi Guizhi Decoction granules+Methotrexate tablets+ Folic acid tablets;control g ... | The Affiliated Hospital of Yunnan University of Traditional Chinese Medicine | NULL | Recruiting | 18 | 65 | Both | experimental group:36;control group:36; | China | |
7 | ITMCTR2100004321 | 2021-01-2520210125 | 2021-01-2520210125 | Observation on the clinical effect of treating rheumatoid arthritis based on the theory of kidney deficiency and cold coagulation Observation on the clinical effect of treating rheumatoid arthritis based on the theory of kidney de ... | Observation on the clinical effect of treating rheumatoid arthritis based on the theory of kidney deficiency and cold coagulation Observation on the clinical effect of treating rheumatoid arthritis based on the theory of kidney de ... | Rheumatoid Arthritis | control group:Methotrexate tablets + Folic acid tablets;experimental group:Fuzi Guizhi Decoction granules+Methotrexate tablets + Folic acid tablets; control group:Methotrexate tablets+ Folic acid tablets;experimental group:Fuzi Guizhi Decoction gran ... | The Affiliated Hospital of Yunnan University of Traditional Chinese Medicine | NULL | Recruiting | 18 | 65 | Both | control group:36;experimental group:36; | China | |
8 | ChiCTR2100041821 | 2021-01-0120210101 | 2021-01-0620210106 | Observation on the clinical curative effect of external application of Rebi ointment in treating rheumatoid arthritis (damp-heat syndrome) joint pain Observation on the clinical curative effect of external application of Rebi ointment in treating rhe ... | Observation on the clinical curative effect of external application of Rebi ointment in treating rheumatoid arthritis (damp-heat syndrome) joint pain Observation on the clinical curative effect of external application of Rebi ointment in treating rhe ... | Rheumatoid Arthritis | therapy group:Rebi ointment, Methotrexate tablets, Leflunomide tablets, and Folic acid tablets ;Control group:Rebi cream simulant, Methotrexate tablets, Leflunomide tablets, and Folic acid tablets; therapy group:Rebi ointment, Methotrexate tablets, Leflunomide tablets, and Folic acid tablets ;Cont ... | Yunnan Provincial Hospital of Traditional Chinese Medicine/The First Affiliated Hospital of Yunnan University of Traditional Chinese Medicine Yunnan Provincial Hospital of Traditional Chinese Medicine/The First Affiliated Hospital of Yunnan U ... | NULL | Recruiting | 18 | 70 | Both | therapy group:36;Control group:36; | China | |
9 | ITMCTR2100004638 | 2021-01-0120210101 | 2021-01-0620210106 | Observation on the clinical curative effect of external application of Rebi ointment in treating rheumatoid arthritis (damp-heat syndrome) joint pain Observation on the clinical curative effect of external application of Rebi ointment in treating rhe ... | Observation on the clinical curative effect of external application of Rebi ointment in treating rheumatoid arthritis (damp-heat syndrome) joint pain Observation on the clinical curative effect of external application of Rebi ointment in treating rhe ... | Rheumatoid Arthritis | Control group:Rebi cream simulant, Methotrexate tablets, Leflunomide tablets, and Folic acid tablets;therapy group:Rebi ointment, Methotrexate tablets, Leflunomide tablets, and Folic acid tablets ; Control group:Rebi cream simulant, Methotrexate tablets, Leflunomide tablets, and Folic acid tablets ... | Yunnan Provincial Hospital of Traditional Chinese Medicine/The First Affiliated Hospital of Yunnan University of Traditional Chinese Medicine Yunnan Provincial Hospital of Traditional Chinese Medicine/The First Affiliated Hospital of Yunnan U ... | NULL | Recruiting | 18 | 70 | Both | Control group:36;therapy group:36; | China | |
10 | ChiCTR2100050865 | 2020-07-1820200718 | 2021-09-0520210905 | Observation on the efficacy of Tripterygium wilfordii polyglycosides tablets combined with Adamumab in the treatment of rheumatoid arthritis Observation on the efficacy of Tripterygium wilfordii polyglycosides tablets combined with Adamumab ... | A multicenter, prospective, observational study to evaluate the efficacy and safety of Tripterygium wilfordii polyglycosides combined with Adamumab in the treatment of rheumatoid arthritis A multicenter, prospective, observational study to evaluate the efficacy and safety of Tripterygium ... | rheumatoid arthritis | Group 1:Tripterygium wilfordii polyglycoside tablets + Adamu monoclonal antibody;Group 2:Methotrexate tablets + Adamu monoclonal antibody; Group 1:Tripterygium wilfordii polyglycoside tablets + Adamu monoclonal antibody;Group 2:Methotrexat ... | The Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine | NULL | Recruiting | 18 | 80 | Both | Group 1:30;Group 2:30; | Phase 4 | China |